Table 2 Parameter estimates of regression coefficient and the means or proportions of predictors for CKD from the final multivariate Cox’s proportional hazards model.

From: Development and validation of a risk prediction model for chronic kidney disease among individuals with type 2 diabetes

Risk factor

\(\widehat{{\varvec{\beta}}}\)(\(\widehat{{\varvec{S}}{\varvec{E}}}\))

Mean or proportion

HR (95% CI)

p-value

Socio-demographic factors

Age

0.03 (0.01)

59.23

1.03 (1.03, 1.04)

 < 0.001

Duration of type 2 diabetes (years) (< 1 year as reference)

  

 1–5

0.06 (0.10)

0.45

1.06 (0.86, 1.30)

0.56

  > 5

0.24 (0.11)

0.30

1.28 (1.03, 1.58)

0.02

Renal function markers

eGFR (≥ 90 mL/min/1.73m2 as reference)

0.84 (0.08)

0.40

2.31 (1.96, 2.71)

 < 0.001

ACR (< 30 mg/g as reference)

1.05 (0.07)

0.23

2.87 (2.48, 3.31)

 < 0.001

Lipid profiles

HDL-C (male ≥ 40 / female ≥ 50 mg/dl as reference)

0.18 (0.08)

0.56

1.20 (1.03, 1.39)

0.02

Triglyceride (< 150 mg/dL as reference)

0.31 (0.08)

0.37

1.37 (1.18, 1.59)

 < 0.001

Variation in glycemic factors

Variation of HbA1c (%), (≤ 3.9% as reference)

 4.0–8.0

0.19 (0.09)

0.33

1.22 (1.01, 1.46)

0.04

  > 8.0

0.31 (0.10)

0.33

1.36 (1.11, 1.67)

0.003

Variation of fasting plasma glucose (%), (≤ 10.7% as reference)

 10.8–20.3

0.10 (0.10)

0.33

1.10 (0.90, 1.34)

0.34

  > 20.3

0.34 (0.11)

0.33

1.40 (1.14, 1.73)

0.002

Baseline diabetes-related disorders or complications

Diabetes retinopathy

0.29 (0.09)

0.20

1.34 (1.13, 1.58)

 < 0.001

Medication use

Insulin use

0.39 (0.11)

0.08

1.50 (1.21, 1.86)

 < 0.001

Hypertension drug use

0.20 (0.07)

0.37

1.20 (1.04, 1.38)

0.005

  1. CKD chronic kidney disease, eGFR estimate glomerular filtration rate, ACR albumin to creatinine ratio, HDL-C High-density lipoprotein, variation of FPG variation of fasting plasma glucose, HR hazard ratio, CI confidence intervals.